ZIKA VIRUS: REVIEW OF CURRENT STATUS

Koppala Rvs Chaitanya; Venna R Surya Anusha

doi:10.22159/ajpcr.2018.v11i7.25377

Authors

Koppala Rvs Chaitanya Department of, School of Pharmacy, Guru Nanak Institutions, Ibrahimpatnam -501 506, Telangana, India.
Venna R Surya Anusha Department of, School of Pharmaceutical Sciences and Technologies, Jawaharlal Nehru Technological University, Kakinada â€“ 533 003, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i7.25377

Keywords:

Zika virus, Structure, Phylogeny, Guillain-Barre syndrome, Congenital Zika syndrome, Microcephaly, Zika strategic response plan, Zika vaccine, Sofosbuvir, India

Abstract

Zika virus (ZIKV) is a mosquito-borne virus which startled the world with its tremendous outbreaks in Africa, America, Asia, and Pacific region. Although the symptoms are mild such as fever and headache, its complications are severe in newborn: Guillain-Barre Syndrome and congenital Zika syndrome including microcephaly. Its ability to transmit through vector and non-vector means especially vertical transmission made it a potential threat. The World Health Organization with the support of other organizations implemented several programs to eradicate the spread of the virus. Development of a vaccine for ZIKV is still under clinical trials. An anti-hepatitis C drug was repurposed for treating infected persons especially pregnant women to limit vertical transmission of ZIKV. This review focuses on the historical background, structure, phylogeny, transmission, symptoms, diagnosis, prevention, and treatment of ZIKV along with strategies planned for control and monitoring of ZIKV.

Downloads

Download data is not yet available.

Author Biographies

Koppala Rvs Chaitanya, Department of, School of Pharmacy, Guru Nanak Institutions, Ibrahimpatnam -501 506, Telangana, India.

Assistant Professor

Venna R Surya Anusha, Department of, School of Pharmaceutical Sciences and Technologies, Jawaharlal Nehru Technological University, Kakinada â€“ 533 003, Andhra Pradesh, India.

Assistant professor, Pharmaceutics Department.

References

Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and Serological Specificity. Trans R Soc Trop Med Hyg. 1952;46:509-20.

Smithburn KC. Neutralizing antibodies against certain recently isolated viruses in the sera of human beings residing in East Africa. J Immunol 1952;69:223-34.

Macnamara FN. Zika virus: A report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954;48:139-45.

Kindhauser MK, Allen T, Frank V, Santhana R, Dye C. Zika: The origin and spread of a mosquito-borne virus. Bull World Health Organ 2016. DOI: org/10.2471/BLT.16.171082.

Foy BD, Kobylinski KC, Foy JL, Blityich BJ, Rosa AT, Haddow AD, et al. Probable non-vector-borne transmission of zika virus, Colorado, USA. Emerg Infect Dis 2011;17:880-2.

Besnard M, LastÃ¨re S, Teissier A, Cao-Lormeau VM, Musso D. Evidence of perinatal transmission of Zika virus, French polynesia. Euro Surveill 2014;19:pii20751.

Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, et al. Potential for zika virus transmission through blood transfusion demonstrated during an outbreak in french polynesia, november 2013 to february 2014. Euro Surveill 2014;19:pii:20761.

FDA. Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components. Maryland, US. August 2016. Available from: https://www.fda.gov/downloads/ biologicsbloodvaccines/guidancecomplianceregulatoryinformation/ guidances/blood/ucm518213.

WHO. Prevention of Sexual Transmission of Zika Virus. Interim Guidance Update. Geneva. 6 September 2016. WHO/ZIKV/MOC/16.1 Rev. 3. Available from: http://www.who.int/csr/resources/publications/ Zika/sexual-transmission-prevention/en.

WHO. Zika Strategic Response Plan Revised For July 2016-December 2017. Geneva. June 2016. Available from: http://www.apps.who. int/iris/bitstream/10665/246091/1/WHO-ZIKV-SRF-16.3-eng. pdf?ua=1&ua=1&ua=1&ua=1.

Bushak L. A Brief History of Zika Virus, from its Discovery in the Zika Forest to the Global Outbreak Today. Medical Daily. 8 April 2016. Available from: http://www.medicaldaily.com/Zika-virus-outbreak-history-381132.

Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG, et al. The 3.8Ã… resolution cryo-EM structure of zika virus. Science (New York, NY) 2016;352(6284):467-70.

Ye Q, Liu ZY, Han JF, Jiang T, Li XF, Qin CF. Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas. Infect Genet Evol 2016;43:43-9.

Boorman JP, Porterfield JS. A simple technique for infection of mosquitoes with viruses; transmission of Zika virus. Trans R Soc Trop Med Hyg 1956;50:238-42.

Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 1969;18:411-5.

Olson JG, Ksiazek TG, Triwibowo S. Zika virus, a cause of fever in central Java, Indonesia. Trans R Soc Trop Med Hyg 1981;75:389-93.

Song BH, Lee YM. Zika virus: History, epidemiology, transmission, and clinical presentation. J Neuroimmunol 2017;308:50-64.

Kuehnert MJ, Basavaraju SV, Moseley RR, Pate LL, Galel SA, Williamson PC, et al. Screening of blood donations for Zika virus infection-Puerto Rico. Morb Mortal Wkly Rep 2016;24:65:627-8.

Barjas-Castro ML, Angerami RN, Cunha MS, Suzuki A, Nogueira JS, Rocco IM, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016;56:1684-8.

Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S, Hennessey M, et al. Male-to-male sexual transmission of Zika virusâ€“texas. MMWR Morb Mortal Wkly Rep 2016;65:372-4.

Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected female-to-male sexual transmission of zika virus-New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65:716-7.

Barzon L, Pacenti M, Franchin E, Lavezzo E, Trevisan M, Sgarabotta D, et al. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti To Italy, January 2016. Euro Surveill 2016;21:pii30316.

Ognjan A, Boulton ML, Somsel P, Stobierski MG, Stoltman G, Downes K, et al. Possible west Nile virus transmission to an infant through breast-feeding-Michigan. MMWR Morb Mortal Wkly Rep 2002;51:877-8.

Barthel A, Gourinat AC, Cazorla C, Joubert C, Dupont-Rouzeyrol M, Descloux E. Breast milk as a possible route of vertical transmission of dengue virus? Clin Infect Dis 2013;57:415-7.

Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of zika virus associated with an epidemic, yap state, Micronesia, 2007. Emerg Infect Dis 2008;14:1232-9.

WHO. Guillainâ€“BarrÃ© Syndrome, Fact Sheet Geneva. October 2016. Available from: http://www.who.int/mediacentre/factsheets/guillainbarre-syndrome/en/.

Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of guillainâ€“barrÃ© syndrome. Lancet Neurol 2016;7:939-50.

Parra B, Lizarazo J, JimÃ©nez-Arango JA, Zea-vera AF, GonzÃ¡lez- Manrique G, Vargas J, et al. Guillainâ€“barrÃ© syndrome associated with Zika virus infection in Colombia. N Engl J Med 2016;375:1513-23.28.

Center for Disease Control and Prevention. Facts about Microcephaly. Georgia, United States. November 2017. Available from:29. https:// www.cdc.gov/ncbddd/birthdefects/microcephaly.html.

Mlakar J, Korya M, Tul N, Popoyic M, Prijatelj MP, Mraz J. Zika virus associated with microcephaly. N Engl J Med 2016;374:951-8.

Gladwyn-Ng I, CordÃ³n-Barris L, Alfano C, Creppe C, Couderc T, Morelli G. Stress-induced unfolded protein response contributes to Zika virus-associated microcephaly. Nat Neurosci 2018;21:63-71.

Center for Disease Control and Prevention. Congenital Zika Syndrome and Other Birth Defects. Georgia, United States. November 2017. Available from: https://www.cdc.gov/pregnancy/Zika/testing-follow-up/Zika-syndrome-birth-defects.html.32.

Beckham JD. Zika virus is associated with microcephaly and eye abnormalities in neonates. Neurol Rev 2016;24:13.

U.S. Department of Health and Human Services. Food and Drug Administration. Emergency Use Authorizations, Maryland 2016. Available from: https://www.fda.gov/MedicalDevices/Safety/ EmergencySituations/ucm161496.htm#Zika.34.

Centers for Disease Control and Prevention. Guidance for US Laboratories Testing for Zika Virus Infection. Georgia, United States. July 24, 2017. Available from: https://www.cdc.gov/Zika/laboratories/lab-guidance.html.

WHO. Information for Travellers Visiting Zika Affected Countries. Geneva. April 2017. Available from: http://www.who.int/csr/disease/ Zika/information-for-travelers/en/.

WHO. Promising New Tools to fight Aedes mosquitoes. Bull World Health Organ 2016;94:562-3. Available from: http://www.who.int/ bulletin/volumes/94/8/16-020816.pdf.

WHO. Zika Strategic Response Plan Quarterly Update. Geneva. October 2016. Available from: http://www.who.int/emergencies/Zika-virus/response/en/.

Abdullahi HS, Umar SH. An overview of recombinant vaccine technology, adjuvants and vaccine delivery methods. Int J Pharm Pharm Sci 2016;8:19-24. Available from: https://www.innovareacademics.in/ journals/index.php/ijpps/article/view/14311/7769.39.

Tebas P, Roberts CC, Muthumani K, Reuschel EL. Safety and immunogenicity of an antiâ€“zika virus DNA vaccineâ€”preliminary report. N Engl J Med 2017. DOI: 10.1056/NEJMoa1708120.

Mesci P, Macia A, Moore SM, Shiryaev SA, Pinto A, Huang CT. Blocking zika virus vertical transmission. Sci Reports 2018;8:1218.

Indian Council of Medical Research Division of Epidemiology and Communicable Diseases. Zika Virus Preparedness and Response. Delhi; 2017. Available from: http://www.who.int/csr/don/26-may- 2017-Zika-ind/en/.

Akunne MO, Chukwueke UC, Anosike C. Assessment of knowledge of zika virus infection among health care professionals in a Southeastren state of Nigeria. Int J Pharm Pharm Sci 2018;10:56-60. Available from: https://www.innovareacademics.in/journals/index.php/ijpps/article/ view/22634/13851.